N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway
2022 · Biology Direct · 38 citations
https://doi.org/10.1186/s13062-022-00347-5
C
Chengjie Lin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
529
Citations
14
h-index
14
i10-index
Chengjie Lin is an academic researcher from Fujian Medical University. The author has contributed to research in topics: RNA modifications and cancer & Cancer-related molecular mechanisms research & Cancer-related gene regulation. The author has an h-index of 14, co-authored 21 publications.
ORCID: 0000-0003-3194-0380Papers by this author
worksN6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer
2022 · Cell & Bioscience · 33 citations
https://doi.org/10.1186/s13578-022-00844-0
Additional file 1 of N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21582799
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat